Andrea Corcoran

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Boston, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Andrea Corcoran
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Andrea Corcoran

Form 4 holding Chief Financial Officer, Executive Vice President, Legal and Secretary

Atea Pharmaceuticals, Inc.

Security class
Common Stock
Shares / value
823,576
Estimated value
$3,417,840
Report date
11 Mar 2026
Price
$4.15
Ownership
Direct
Form 4 holding Chief Financial Officer, Executive Vice President, Legal and Secretary

Atea Pharmaceuticals, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$32,130
Report date
31 Jan 2026
Price
$3.06
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer, Executive Vice President, Legal and Secretary

Atea Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
11 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Andrea Corcoran

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .